Innocan Pharma Corporation ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce promising results from a multi-year compassionate therapy ...
BP expects a net debt increase in Q3 due to lower refining margins and changes in asset sale timing. The company faces reduced earnings of up to $600 million, signaling a weaker outlook for the oil ...
The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience.